The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic values of cell free DNA, CA 15.3, and ESR1 circulating mutations variations in hormone receptor (HR)-positive metastatic breast cancer (MBC) patients under aromatase inhibitor (AI).
 
Laetitia Augusto
No Relationships to Disclose
 
Ludivine Beaussire
No Relationships to Disclose
 
Justine Lequesne
No Relationships to Disclose
 
Anne Perdrix
Consulting or Advisory Role - Bristol-Myers Squibb (I); Merck Serono (I)
Research Funding - AstraZeneca (Inst)
 
David Sefrioui
Expert Testimony - Amgen; Ipsen
Travel, Accommodations, Expenses - Amgen; Ipsen; Novartis; Pfizer; Sandoz; SERVIER
 
Maxime Fontanilles
No Relationships to Disclose
 
Marianne Leheurteur
Honoraria - Pfizer
Travel, Accommodations, Expenses - Eisai; Novartis; PharmaMar; roche; Roche
 
Frédéric Di Fiore
Consulting or Advisory Role - Amgen; Bayer; Ipsen; Janssen; Lilly; Merck; Novartis; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen; Ipsen; Lilly; Merck; Novartis; Roche; Sanofi
 
Nasrin Sarafan-Vasseur
No Relationships to Disclose
 
Florian Clatot
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck
Research Funding - AstraZeneca (Inst)